Acclarent, Inc. is a medical device company in Menlo Park, CA that was established in June of 2004. The company is dedicated to the development of innovative devices providing new technologies to further meet the needs of ENT patients. Acclarent's initial focus is on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools - Balloon Sinuplastyâ„¢ devices. Through the Balloon Sinuplastyâ„¢ technology and our RelievaÂ:registered: product portfolio we offer ENT patients alternatives to conventional endoscopic surgical approaches. FDA clearances for these devices were completed in 2005 and the products were commercially launched in the US that same year. Through our core technologies and commitment to innovation, Acclarent will continue to advance novel devices in all areas of ENT.

Ogawa & Co., Ltd. is a private company headquartered in Japan, with subsidiaries in CN, that develops, manufactures and sells food flavors and fragrances for cosmetics and toiletries.

Shanghai Nuosiqing Biotechnology Co., Ltd., established on 2011-05-19, Business scope includes licensed projects:food business;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:engaged in biotechnology,medical instruments,Technology development in the field of rubber and plastic materials technology,technology transfer,technical consulting,Technical Services,account Serive,Exhibition display service,design,Create various advertisements,marketing planning,Packaging Materials,Electronic Component,Rubber products,electronics,Toy,Daily necessities,Daily Chemicals,hygiene products,cosmetic,the first sort,Sales of Class II Medical Devices,Import and export,Technology Import and Export,e-commerce(Not to engage in financial business).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Chengdu Sirining Technology Co., Ltd., established on 2016-09-12, Business scope includes software development;Technical extension services;Information Technology Consulting Services;Business Management Consulting Services;Nutrition and Health Consulting;Import and export;Technology Import and Export;Sales:medical instruments,food,Stationery,cosmetic,Equipment,electronic product.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Bayer Schering Pharma AG is a research-centered pharmaceutical company that was formed by the merger of Schering with Bayer on 29 December 2006. The company was originally founded in 1851 by Ernst Christian Friedrich Schering. The company employs more than 26,000 people in 140 subsidiaries all over the world. The company's headquarters are in Berlin-Wedding, Germany and the forerunner company Schering's annual gross revenue was nearly € 5 billion. They retain the largest German manufacturing facility which is located in Bergkamen. The company focuses on the business areas of gynaecology and andrology, oncology, and also special therapeutics, diagnostical devices, and nuclear medicine. Schering's best-known product is their line of combined oral contraceptive pills. Through Bayer Healthcare AG, Bayer Schering Pharma is a full member of the European Federation of Pharmaceutical Industries and Associations.

Guangdong Kangerle Medical Equipment Co., Ltd., established on 2014-02-18, Business scope includes general items:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;mold making;Mold Sales;Manufacturing of plastic products;Sales of plastic products;Rubber Products Sales;Manufacturing of rubber products;electronics sales;Manufacturing of hardware products;Hardware retail;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Import and export;Technology Import and Export;Business agency service;Sales of hygiene products and single-use medical products.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of Class II Medical Devices;Production of hygiene products and single-use medical products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

The Vygon Company strategy is clear, offer health professionals efficient and innovative single-use medical products adapted to their needs. With a high degree of quality and at a competitive price, we offer health-care professionals the best possible chances to treat and care for their patients in the most secured conditions. Innovation requires an understanding: our teams of marketing, R&D and sales representatives are working daily with our customers, listening to their needs, bringing creative and imaginative solutions to patient care. This high quality and responsive service compliments the proximity of production and research. That is why our plants are still located in Europe and in the United States of America. It’s our key to ensure constant high quality products. This policy and strategy, requires long term commitment and a real involvement of all Vygon partners and managers. Stability and commitment of our shareholders enable us to invest in the long term, opting for quality and innovation instead of short term profitability, giving our teams and clients the warranty of a long term vision that everybody needs. This willingness to act in the long term, some talk about Sustainable Development Strategy (SDS), allows Vygon to implement its leading vision of progress, integrating all stakeholders, in social, economic and environmental outcomes. This strategy has proven to be effective. Since fifty years now, Vygon attracts more and more partners around the world. We are now present in more than one hundred countries in five continents. Our regular growth and profitability, warranty of our independence and our ability to innovate, testifies the quality of our products and our customer satisfaction.

Bio 54 LLC is an American company located in Chapel Hill, NC, that develops topical anti-coagulant drugs. Margaret Powell is currently the CEO of the firm.

Seoul National University Hospital (서울대학교병원) is one of the oldest and biggest hospitals in South Korea. It is a general and teaching hospital of Seoul National University's College of Medicine. Except SNUH Healthcare System Gangnam Center, all branches have an emergency department (ED).

Suzhou Xinsida Medical Technology Co., Ltd., established on 2018-09-06, Business scope includes research and development,Production,Sales:medical instruments,Biological product;research and development,Sales:Disinfectant,Daily necessities,hygiene products,Beauty Supplies and Equipment;medical technology,Technology development in the field of biotechnology,technical consulting,Technical Services,technology transfer;Medical Information Consulting Service,Medical Information Consultation,Business Management Consulting,Quality Management System Certification Consulting,Science and Technology Information Consulting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jiangxi Lecheng Biomedical Co., Ltd., established on 2016-07-18, Business scope includes licensed projects:Production of Class II Medical Devices,Class III medical device business,Drug import and export,Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Sales of Class II Medical Devices,Sales of Class I Medical Devices,Transport cargo packing service(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Tianjin Pacific Pharmaceutical Co., Ltd., established on 1994-08-08, Business scope includes production,Sales of Chinese and Western medicine preparations(Production and sales according to the business scope stipulated in the drug production license),Owned Commercial Facility Lease;food,Cosmetic production,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)